Articles by Barts Cancer Institute

£3.1 million for PROTECT trial

6th May 2022

Yorkshire Cancer Research has announced a £3.1 million grant for research led by Ranjit Manchanda to investigate the risks, benefits, and feasibility of introducing population-based genetic testing for ‘all’ women to find out if they are at high risk of cancer. Thousands of women living in Yorkshire and other parts of the UK will be offered tests as part of the PROTECT (Population based germline testing for early detection and cancer prevention) clinical trial.

Read more

International Day of Women and Girls in Science

11th February 2022

This International Day of Women and Girls in Science, Radhisha Kohombage, an MSc student at BCI, spoke to some fellow students, to hear more about their roles, inspirations, and advice for the next generation who would like to pursue a career in science.

Read more

Our Pancreatic Cancer Research: From BCI Bench to Bedside

18th November 2021

Pancreatic cancer is a core area of research focus at the Barts Cancer Institute, Queen Mary University of London, with a major aim being direct translation of laboratory research into clinical trials with the hope of improving outcomes for patients. Find out more this World Pancreatic Cancer Day.

Read more

Search News